Monday, January 3, 2011
Year in Review: More Scrutiny of Dietary Supplements
Hello how was every one's holiday break?
hopefully well i know we all deserved a little vacation to spend with our families. With holidays comes some extra holiday weight and we are are back on track somehow with trying to get back in shape whether it be hitting the gym, dieting or taking a dietary supplement.
The U.S. Food and Drug Administration has been busy this year issuing statements and recalls regarding dietary supplements discovered to contain undeclared drug ingredients. Studies have shown that some supplements may increase potentially lethal risks to patients and contain varying amounts of active compounds between brands. And through all this, patients and doctors are not talking to each other about the use of dietary supplements.
So, where are we now?
Read this story on www.medpagetoday.com.
The FDA's latest statement largely concerned a major issue in the dietary supplement market -- that safety and efficacy standards are in the hands of manufacturers. As a result, pills, powders, and other products that contain drug or drug-like ingredients may be released and marketed as dietary supplements despite being drug products, the FDA statement said.
"These tainted products can cause serious adverse effects, including strokes, organ failure, and death," Dr. Margaret A. Hamburg, commissioner of the FDA, said in the statement.
The statement noted the FDA and supplement industry are working together to stem the flow of illegally marketed drug products sold under the veil of "dietary supplements," including weight-loss, body-building, and sexual enhancement products.
"Part of the difficulty in regulating dietary supplements is that [some companies] operate outside of the law and don't include manufacturer information on the label, so it can be impossible to contact someone and request a recall," an FDA spokesperson told MedPage Today.
"If you're thinking about taking a supplement, always talk to a healthcare provider first -- they know you best and what drugs you're taking," the spokesperson said.
But the poor communication is not entirely an industry-side faux pas, Jennifer Strohecker of the Intermountain Medical Center in Murray, Utah, told MedPage Today.